Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts.
Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio.
Corbus Pharmaceuticals (CRBP) – This is a clinical-stage biotech company developing treatments for cancer and obesity. Yesterday, Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on the stock and increased the price target to $40 from $39 per share. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 312.78%.
Aviat Networks (AVNW) – Aviat Networks provides wireless transport and networking solutions. Yesterday, Roth MKM analyst Scott Searle maintained a Buy rating on the stock with a price target of $38 per share. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 68.28%.
Context Therapeutics (CNTX) – This is a clinical-stage biotech company developing targeted cancer therapies, especially for solid tumors. Yesterday, LifeSci Capital analyst Charles Zhu maintained a Buy rating on the stock with a price target of $6 per share. In the last three months, all five Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of 91.18%.